Leflunomide, a common drug for rheumatoid arthritis, has recently been reported to be able to inhibit the angiogenesis and tumor growth in bladder cancer by decreasing the expression of EFNA1 [39]. Here, EFNA1 is linked to urinary bladder cancer.